130 related articles for article (PubMed ID: 38511030)
1. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?
Dave S; Choudhury A; Alurkar SS; Shah AM
Indian J Surg Oncol; 2024 Mar; 15(1):44-52. PubMed ID: 38511030
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Jain P; Doval DC; Batra U; Goyal P; Bothra SJ; Agarwal C; Choudhary DK; Yadav A; Koyalla VPB; Sharma M; Dash P; Talwar V
Jpn J Clin Oncol; 2019 Apr; 49(4):329-338. PubMed ID: 30753543
[TBL] [Abstract][Full Text] [Related]
3. Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).
Agrawal S; Banswal L; Saha A; Arun I; Datta SS; Chatterjee S; Ahmed R
Indian J Surg Oncol; 2016 Dec; 7(4):397-406. PubMed ID: 27872526
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Carcinoma Using Image-Guided Clip Placement.
Pandurangappa V; Paruthy SB; Jamwal R; Singh A; Tanwar S; Kumar D; Pal S; Mohan SK; Das A; Trs PR
Cureus; 2023 Oct; 15(10):e47763. PubMed ID: 38021852
[TBL] [Abstract][Full Text] [Related]
5. Molecular Subtypes As Emerging Predictors of Clinicopathological Response to Neoadjuvant Chemotherapy (NACT) in Locally Advanced Breast Cancer (LABC): A Single-Centre Experience in Western India.
Sharma S; Rathore SS; Verma V; Kalyan M; Singh N; Irshad I
Cureus; 2022 May; 14(5):e25229. PubMed ID: 35755569
[TBL] [Abstract][Full Text] [Related]
6. Locally Advanced Breast Cancer: Response Evaluation to Neoadjuvant Chemotherapy by Clinico-Histopathological Parameters and Molecular Imaging.
Jain AK
Indian J Surg Oncol; 2023 Jun; 14(2):279-287. PubMed ID: 37324312
[TBL] [Abstract][Full Text] [Related]
7. Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Chatterjee D; Bal A; Das A; Singh G
Virchows Arch; 2015 Sep; 467(3):303-10. PubMed ID: 26063415
[TBL] [Abstract][Full Text] [Related]
8. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
[TBL] [Abstract][Full Text] [Related]
10. The accuracy of MRI in detecting pathological complete response following neoadjuvant chemotherapy in different breast cancer subtypes.
Kuzmova M; Cullinane C; Rutherford C; McCartan D; Rothwell J; Evoy D; Geraghty J; Prichard RS
Surg Oncol; 2023 Dec; 51():102011. PubMed ID: 37931546
[TBL] [Abstract][Full Text] [Related]
11. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
12. Pathological predictive factors for tumor response in locally advanced breast carcinomas treated with anthracyclin-based neoadjuvant chemotherapy.
Patel T; Gupta A; Shah M
J Cancer Res Ther; 2013; 9(2):245-9. PubMed ID: 23771367
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.
Li XR; Liu M; Zhang YJ; Wang JD; Zheng YQ; Li J; Ma B; Song X
Med Oncol; 2011 Dec; 28 Suppl 1():S31-8. PubMed ID: 20844986
[TBL] [Abstract][Full Text] [Related]
14. HER2-positive is an independent indicator for predicting pathological complete response to neoadjuvant therapy and Ki67-changed after neoadjuvant chemotherapy predicts favorable prognosis in Chinese women with locally advanced breast cancer.
Fang Y; Zhang Q; Wu Y; Wu J
Medicine (Baltimore); 2024 Feb; 103(6):e37170. PubMed ID: 38335419
[TBL] [Abstract][Full Text] [Related]
15. Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer.
Gopinath P; Veluswami S; Gopisetty G; Sundersingh S; Rajaraman S; Thangarajan R
Breast Cancer Res Treat; 2022 Jul; 194(2):207-220. PubMed ID: 35597840
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of breast conservation surgery in locally advanced breast cancer downstaged by neoadjuvant chemotherapy: a study in mastectomy specimens using simulation lumpectomy.
Viswambharan JK; Kadambari D; Iyengar KR; Srinivasan K
Indian J Cancer; 2005; 42(1):30-4. PubMed ID: 15805689
[TBL] [Abstract][Full Text] [Related]
17. Development of a nomogram for predicting survival of breast cancer patients with neoadjuvant chemotherapy: a dynamic analysis for systemic inflammation response index.
Huang W; Xiong Z; Zhong W; Zhang C; Feng J; Wang X
Gland Surg; 2023 Nov; 12(11):1459-1474. PubMed ID: 38107499
[TBL] [Abstract][Full Text] [Related]
18. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
19. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
20. A Novel Model Incorporating Tumor Stiffness, Blood Flow Characteristics, and Ki-67 Expression to Predict Responses After Neoadjuvant Chemotherapy in Breast Cancer.
Zhang J; Gao S; Zheng Q; Kang Y; Li J; Zhang S; Shang C; Tan X; Ren W; Ma Y
Front Oncol; 2020; 10():603574. PubMed ID: 33364197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
